OliX PharmaceuticalsInc (226950) - Total Liabilities

Latest as of March 2026: ₩40.96 Billion KRW ≈ $27.76 Million USD

Based on the latest financial reports, OliX PharmaceuticalsInc (226950) has total liabilities worth ₩40.96 Billion KRW (≈ $27.76 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 226950 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

OliX PharmaceuticalsInc - Total Liabilities Trend (2016–2025)

This chart illustrates how OliX PharmaceuticalsInc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of OliX PharmaceuticalsInc.

OliX PharmaceuticalsInc Competitors by Total Liabilities

The table below lists competitors of OliX PharmaceuticalsInc ranked by their total liabilities.

Company	Country	Total Liabilities
Tien Phong Commercial Joint Stock Bank VN:TPB	Vietnam	₫459.85 Trillion
Jiangsu Lopal Tech Co Ltd SHG:603906	China	CN¥14.61 Billion
Thai Union Group Public Company Limited BK:TU-R	Thailand	฿108.00 Billion
Thai Union Group PCL BK:TU	Thailand	฿107.93 Billion
Neinor Homes SLU MC:HOME	Spain	€2.42 Billion
Anterix Inc NASDAQ:ATEX	USA	$212.13 Million
Vedant Fashions Limited NSE:MANYAVAR	India	Rs8.88 Billion
Shiny Chemical Industrial Co Ltd TW:1773	Taiwan	NT$5.69 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down OliX PharmaceuticalsInc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of OliX PharmaceuticalsInc to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.59	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OliX PharmaceuticalsInc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OliX PharmaceuticalsInc (2016–2025)

The table below shows the annual total liabilities of OliX PharmaceuticalsInc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩45.29 Billion ≈ $30.69 Million	-15.19%
2024-12-31	₩53.40 Billion ≈ $36.19 Million	+1.74%
2023-12-31	₩52.49 Billion ≈ $35.57 Million	-21.36%
2022-12-31	₩66.74 Billion ≈ $45.23 Million	-2.06%
2021-12-31	₩68.15 Billion ≈ $46.18 Million	+104.71%
2020-12-31	₩33.29 Billion ≈ $22.56 Million	+876.59%
2019-12-31	₩3.41 Billion ≈ $2.31 Million	+387.74%
2018-12-31	₩698.94 Million ≈ $473.66K	-76.42%
2017-12-31	₩2.96 Billion ≈ $2.01 Million	+14.35%
2016-12-31	₩2.59 Billion ≈ $1.76 Million	--

About OliX PharmaceuticalsInc

KQ:226950 Korea Biotechnology

Market Cap

$1.49 Billion

₩2.20 Trillion KRW

Market Cap Rank

#7259 Global

#183 in Korea

Share Price

₩108300.00

Change (1 day)

+8.19%

52-Week Range

₩81700.00 - ₩207000.00

All Time High

₩207000.00